Today, we will break down Dexcom. Founded in 1999, Dexcom makes best-in-class continuous glucose monitors to help diabetics manage their blood sugar levels. With close ties to growing obesity rates, the diabetes market is big, expensive, and expanding. In the US alone, one-third of Americans are diabetic or pre-diabetic, and the cost of treating diabetes is expected to double over the next decade.   To break down Dexcom, Zack Fuss is joined by Aneal Tenjarla, an associate portfolio manager at Sofinnova BioEquities and an investor in Dexcom. During our conversation, we discuss how Dexcom's continuous glucose monitors have materially changed treatment, we cover the structure of the market and Dexcom’s competitors, and we discuss where the business may have future runway inside and outside of diabetes care.   I hope you enjoy this breakdown of Dexcom.   For the full show notes, transcript, and links to the best content to learn more, check out the episode page here. -----   Business Breakdowns is a property of Colossus, Inc. For more episodes of Business Breakdowns, visit joincolossus.com/episodes.   Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.   Follow us on Twitter: @JoinColossus | @patrick_oshag | @jspujji | @zbfuss   Show Notes [00:02:37] - [First question] - What is Dexcom, their core product, and the size of their market [00:04:43] - Overview of the expenses that diabetics accrue annually [00:06:36] - Why continuous glucose monitors (CGMs) are important for diabetes management [00:09:57] - Dexcom’s unit economics and their current revenue model [00:14:10] - Whether or not there is a tech and regulatory barrier to entry  [00:16:18] - How a diabetic or prediabetic finds their way to a Dexcom device [00:17:41] - Their current customer base and their revenue streams [00:19:31] - What dictates if a practitioner will refer patients to Dexcom or Abbott [00:21:56] - Why the problem Dexcom aims to solve is so culturally relevant today [00:25:12] - What the next chapter for Dexcom’s business could be [00:28:51] - Sizing the opportunity and optionality in this industry [00:32:11] - Thoughts on Dexcom’s capital allocation decisions [00:34:22] - Reasons why Dexcom could potentially fail in the future [00:37:59] - Competitors arising in the wearable CGM space [00:39:49] - Overview of their management team and what a good one looks like [00:42:52] - Whether or not they plan on stepping into the pump and insulin space [00:45:20] - Other externalities that consumer-friendly CGMs could create for consumers and insurance companies [00:48:56] - Lessons for builders and investors when studying Dexcom’s story [00:53:21] - A future where CGMs could be mostly implants [00:54:18] - The value unlock consumer-friendly monitoring will provide

Today, we will be breaking down ZoomInfo. Founded as DiscoverOrg in 2007, ZoomInfo is a go-to-market software & data solution for B2B sales. When a sales rep gains access to ZoomInfo, they gain access to a database with over 130 million contacts. The ZoomInfo platform assists in finding potential customers, contacting those potential customers, and refining each phase of the workflow.   To help break down ZoomInfo, host Jesse Pujji is joined by its CEO, Henry Schuck. Henry founded DiscoverOrg and acquired ZoomInfo in 2019. During our conversation, we cover how ZoomInfo differs from traditional CRM businesses, its unique gross margin profile, their special go-to-market muscle, and Henry’s approach to M&A. As a founder, I love stories about bootstrapped businesses, and Henry’s does not disappoint. I hope you enjoy this breakdown of ZoomInfo.   For the full show notes, transcript, and links to the best content to learn more, check out the episode page here. -----   Business Breakdowns is a property of Colossus, Inc. For more episodes of Business Breakdowns, visit joincolossus.com/episodes.   Stay up to date on all our podcasts by signing up to Colossus Weekly, our quick dive every Sunday highlighting the top business and investing concepts from our podcasts and the best of what we read that week. Sign up here.   Follow us on Twitter: @JoinColossus | @patrick_oshag | @jspujji | @zbfuss   Show Notes [00:02:35] - [First question] - What is ZoomInfo and their current scale [00:04:19] - The problem that ZoomInfo solves and an overview of their product [00:07:23] - A consumer-friendly description of what ZoomInfo is  [00:11:13] - The value unlock their database provides salespeople [00:13:28] - Big milestones when bootstrapping the business and their history [00:19:20] - Big problems that had to be solved when building the business [00:21:26] - Giving us a sense of the data market today [00:23:58] - Whether or not they play in a competitive landscape [00:26:36] - The P&L of ZoomInfo and metrics he pays attention to  [00:28:18] - Getting the data for their database and the costs associated with it [00:30:03] - Improving their service the more data they accumulate [00:31:48] - Overview of their contracts when offering the service to a business [00:32:35] - Various components of their sales and marketing strategy [00:35:35] - Same day sales cycles and how that manifests itself in ZoomInfo [00:38:48] - What separates ZoomInfo; they sell to sellers and their velocity  [00:40:31] - Their approach to M&A in strategy, valuation, and funding  [00:44:16] - Things they say no to when it comes to M&A  [00:47:19] - How they approached the funding side of their acquisitions [00:48:06] - Why they chose to go public [00:49:52] - Notable moments in how the business responded to the pandemic [00:52:24] - Key factors that would allow ZoomInfo to double their market cap in ten years [00:54:03] - Potential opportunities in AI and data science sectors [00:55:20] - What keeps him up at night in regards to their future success [00:57:12] - Ways he invests in his abilities that other CEOs could learn from [00:57:54] - Whether or not BigTech poses a threat to their data accumulation [01:01:48] - Lessons for builders and investors when studying ZoomInfo’s story [01:03:28] - Learn more about their space; A World of DaaS Podcast